Manhattan Hematology Oncology (MHO) Research Foundation, Inc. — New York, New York

Manhattan Hematology Oncology (MHO) Research Foundation, Inc. is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Manhattan Hematology Oncology (MHO) Research Foundation, Inc. has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation.

Sponsors: Cardiff Oncology.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Manhattan Hematology Oncology (MHO) Research Foundation, Inc.?

Manhattan Hematology Oncology (MHO) Research Foundation, Inc. has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Manhattan Hematology Oncology (MHO) Research Foundation, Inc. conducted?

Manhattan Hematology Oncology (MHO) Research Foundation, Inc. has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation.

Is Manhattan Hematology Oncology (MHO) Research Foundation, Inc. accredited by Crixeo Health?

Manhattan Hematology Oncology (MHO) Research Foundation, Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Manhattan Hematology Oncology (MHO) Research Foundation, Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.